Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test Combined Screening- AutoDELFIA (LifeCycle) is typically 5-7 business days from the time of sample collection.

What are the prerequisites for the test Combined Screening- AutoDELFIA (LifeCycle)

  • Age: The individual must be between the ages of 15 and 35 years old.
  • Sex: The test is suitable for both males and females.
  • Pregnancy: The test is not suitable for pregnant women.
  • Sample Collection: A blood sample must be collected for the test.
  • Fasting: The individual must fast for at least 4 hours before the test.
  • Medication: The individual should not be taking any medications that may interfere with the test results.

What are the measure values for the test Combined Screening- AutoDELFIA (LifeCycle)

  • Alpha-fetoprotein (AFP) - ng/mL
  • Free beta-hCG - mIU/mL
  • Unconjugated estriol (uE3) - ng/mL
  • hCG - mIU/mL
  • PAPP-A - mIU/L

What does this test Combined Screening- AutoDELFIA (LifeCycle) identify?

This test, Combined Screening- AutoDELFIA (LifeCycle), is used to identify certain genetic disorders and abnormalities in a developing fetus during pregnancy. It combines two screening tests - the first trimester screening test and the quad screen test.

The first trimester screening test involves a blood test and an ultrasound to assess the risk of Down syndrome and other chromosomal abnormalities. The quad screen test, on the other hand, is a blood test that checks for markers associated with neural tube defects and genetic disorders such as Down syndrome and trisomy 18.

By combining these two tests, healthcare providers can provide more accurate information about the risk of certain genetic conditions in the fetus, allowing parents to make informed decisions about their pregnancy.

Why is this test Combined Screening- AutoDELFIA (LifeCycle) taken?

The Combined Screening- AutoDELFIA (LifeCycle) test is taken to assess the risk of certain chromosomal abnormalities in the fetus during pregnancy. This test combines a blood test and an ultrasound to determine the likelihood of conditions such as Down syndrome, trisomy 18, and neural tube defects. It is typically offered to pregnant women between 11 and 14 weeks of gestation to provide early information about the health of the fetus and allow for further testing or counseling if needed.

No FAQs available.

Customer Google Rating